Translational progress in regenerative lung therapy

The autumn 2025 development program also marked a significant milestone in The Bridge’s translational pipeline, strengthening the connection between laboratory innovation and clinical implementation. Through coordinated experimental workflows, standardized protocols, and cross-border collaboration, the center further refined its approach to treating damaged donor lungs using advanced cellular therapies.

These efforts highlight The Bridge - Lungs for Life’s commitment to building scalable regenerative solutions and expanding the pool of transplantable lungs, bringing us closer to a future where more patients can benefit from life-saving lung transplantation.

Filming in the laboratory